MAPK3 and neoplasm: On the basis of our results, CD13 inhibition augmented TRAIL’ s effect in decreasing tumor cell survival through DR4 activation as well as p-ERK1/2 down-regulation; thus, we reasoned that a possible link might exist between these pathways.